Your session is about to expire
← Back to Search
Stent-Graft for Abdominal Aortic Aneurysm
Study Summary
This trial is testing a new stent-graft for people with abdominal aortic aneurysms. They want to see if it's safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a serious issue with my abdominal aorta as diagnosed by my doctor.I have been diagnosed with an abdominal aortic aneurysm below my kidneys.I have an abdominal aortic aneurysm larger than 4.5 cm (if male) or 4.0 cm (if female), or it has grown by 0.5 cm recently.I have had surgery to repair an abdominal aortic aneurysm.
- Group 1: Treovance
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Will this research be conducted with elderly participants?
"Eligibility for this particular clinical trial is restricted to patients that are between 18 and 85 years old. In contrast, there are 8 trials that are only enrolling patients below the age of eighteen and 158 studies recruiting participants above 65."
Are there any more spots left for people who want to participate in this research project?
"From the information on clinicaltrials.gov, it can be gathered that this trial is not presently looking for patients. This trial was initially posted on 11/23/2013 and was last updated on 6/25/2020; however, there are 160 other trials enrolling patients at this time."
Could I qualify to be a subject in this clinical trial?
"Aneurysm patients who are between 18 and 85 years old may be eligible for this study. Up to 150 people can participate."
Does the Treovance stent-graft have FDA approval for use in human subjects?
"This is a Phase 2 trial, which means that while there are safety data, there are no efficacy data. Therefore, the Power team gave it a rating of 2."
Share this study with friends
Copy Link
Messenger